Last updated on May 2019

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement


Brief description of study

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

Detailed Study Description

PEPPER is a large pragmatic clinical trial to inform patient choice and balance risk tolerances of individuals who face decisions about different drugs and strategies for deep vein thrombosis (DVT) and pulmonary embolism (PE) prevention after total hip (THA) and knee (TKA) replacement. Indeed, clinical equipoise exists to ethically support such a randomized trial that has great potential to change current practice. We have selected the three prophylaxis methods that represent current orthopaedic practice in North America and collectively account for more than 80% of all hip and knee replacements; a) enteric coated aspirin (regimen with lowest bleeding risk; clinical PE and all-cause mortality rates comparable to more intensive anticoagulants), b) low intensity (INR Target 2.0) warfarin (time honored and one of the most common North American regimens; low bleeding risk [1-2%]), and c) rivaroxaban, a new oral direct Factor Xa inhibitor (regimen with lowest PE and DVT rate but higher bleeding risk [3-5%]). Prophylaxis will continue for 30 days, in accordance with clinical guidelines, and pneumatic compression will be utilized in hospital in conjunction with each treatment group. Each regimen is commonly used in contemporary practice, supported by observational and clinical trial data, and endorsed by the American College of Chest Physicians (ACCP) and American Academy of Orthopaedic Surgeons (AAOS) guidelines

Clinical Study Identifier: NCT02810704

Find a site near you

Start Over

Lahey Clinic

Burlington, MA United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Sinai Hospital

Baltimore, MD United States
  Connect »

UCLA

Santa Monica, CA United States
  Connect »

Stanford University Hospital

Stanford, CA United States
  Connect »

University of Virginia

Charlottesville, VA United States
  Connect »

New York University

New York, NY United States
  Connect »

Geisinger Medical Center

Danville, PA United States
  Connect »

West Virginia University

Morgantown, WV United States
  Connect »

University of Washington

Seattle, WA United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

Larkin Hospital Miami

South Miami, FL United States
  Connect »

Mayo Clinic

Scottsdale, AZ United States
  Connect »

UCLA

Los Angeles, CA United States
  Connect »

Indiana University

Indianapolis, IN United States
  Connect »

Johns Hopkins University

Baltimore, MD United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.